| Literature DB >> 24602790 |
Manon Roche1, Céline Lacroix2, Omar Khoumeri1, David Franco2, Johan Neyts3, Thierry Terme1, Pieter Leyssen2, Patrice Vanelle4.
Abstract
Human rhinoviruses are a common cause of respiratory infections, and thus constitute an important target for medicinal chemistry. Still, no drug has been approved for clinical use. We report herein the discovery of dibenzenic derivatives with potent and specific in vitro anti-rhinoviral 14 activity. A total of 99 structural analogues were synthesized by an original synthesis method, i.e. through one organic agent Tetrakis(DimethylAmino)Ethylene (TDAE) and a structure-activity relationship was established. It was shown that 4,5-dimethoxy scaffold and the presence of a C-4 substituted aromatic moiety were necessary to the in vitro activity of these original agents. However, modifications on liker were not convincing. The benzonitrile derivative 23 was identified as the most potent and selective inhibitor of rhinovirus replication in these series (EC₅₀ of 2 ± 0.5 μM, CC₅₀ of 184 μM, selectivity index of 92).Entities:
Keywords: 4,5-Dimethoxybenzenes; Antiviral activity; Human rhinovirus 14; Tetrakis(DimethylAmino)Ethylene
Mesh:
Substances:
Year: 2014 PMID: 24602790 DOI: 10.1016/j.ejmech.2014.01.034
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514